Shares of Transcat, Inc. (NASDAQ:TRNS) have been given an average broker rating score of 1.33 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. Transcat’s rating score has improved by 11.3% in the last 90 days as a result of a number of analysts’ ratings changes.
Brokers have set a 12 month consensus target price of $20.00 for the company and are anticipating that the company will post $0.23 EPS for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 58 out of 265 based on the ratings given to related companies.
TRNS has been the topic of several recent research reports. Zacks Investment Research downgraded Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Singular Research initiated coverage on Transcat in a report on Wednesday, November 15th. They issued a “buy” rating and a $15.30 price target on the stock. Finally, Roth Capital assumed coverage on Transcat in a report on Friday, February 9th. They issued a “buy” rating and a $20.00 price target on the stock.
Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.09. The business had revenue of $40.48 million for the quarter. Transcat had a return on equity of 10.03% and a net margin of 3.24%. equities research analysts forecast that Transcat will post 0.7 earnings per share for the current year.
In other Transcat news, Director John T. Smith sold 2,000 shares of Transcat stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the sale, the director now owns 33,100 shares of the company’s stock, valued at approximately $519,670. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 8.80% of the stock is owned by insiders.
A number of institutional investors have recently made changes to their positions in TRNS. Northern Trust Corp raised its stake in Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after acquiring an additional 1,570 shares in the last quarter. Vanguard Group Inc. raised its stake in Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after acquiring an additional 4,450 shares in the last quarter. QCI Asset Management Inc. NY raised its stake in Transcat by 31.1% during the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock valued at $437,000 after acquiring an additional 7,647 shares in the last quarter. Quantum Capital Management bought a new stake in Transcat during the 3rd quarter valued at $696,000. Finally, Ameriprise Financial Inc. bought a new stake in Transcat during the 3rd quarter valued at $2,484,000. 52.94% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: “Transcat, Inc. (TRNS) Given $20.00 Consensus Price Target by Brokerages” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3229106/transcat-inc-trns-given-20-00-consensus-price-target-by-brokerages.html.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.